Skip to main content
Caplight Logo









Paterna Biosciences

Paterna Biosciences

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://paternabio.com/

Last Round

Series A

May 13, 2026

Total Funding Raised

$13.53M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Paterna Biosciences is a biotechnology company that develops in-vitro spermatogenesis (IVS) technology to treat male infertility.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

in vitro spermatogenesisIVSmale infertilityreproductive biotechnologyfertility treatmentIVFtesticular stem cellsnon-obstructive azoospermiacomputational biologybioinformaticsfertility techlab-grown spermprecision medicinesingle-cell genomicsfertility clinic solutions

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Paterna Biosciences Comparables

Compare Paterna Biosciences with similar companies based on industry and business-model similarity.

Paterna Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kallistem
80%
Ovelle Bio Corp.
73%
Conception
73%

Paterna Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 13, 2026
SeedOct 28, 2024
SeedMar 14, 2024
SeedAug 31, 2023

Key People

Founding team and executive leadership

Alex Pastuszak

Cofounder, Chief Executive Officer

Founding Team

Danny Mitchell

Chief Financial Officer

Executive Team

Paterna Biosciences Investors

Notable investors and investment history

Paterna Biosciences investors
InvestorRounds
e184Seed
Freya VenturesSeed
Utah Innovation FundSeed
Seaside VenturesSeed
Capita3Seed
SpringTide VenturesSeed
Divergent CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 61% MoM, reaching 4.9K.

  • Oct 28, 2024

    $11.4M round led by SpringTide Ventures

Paterna Biosciences Filings

Explore SEC and related filing metadata, where available.

Paterna Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Paterna Biosciences's valuation, stock price, and market status.

Is Paterna Biosciences a public or private company?

Paterna Biosciences is a private company.

What is the current stock price of Paterna Biosciences?

Paterna Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Paterna Biosciences worth (valuation)?

Valuation information for Paterna Biosciences is not publicly available.

Can I buy Paterna Biosciences stock?

Paterna Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Paterna Biosciences's last funding round?

Paterna Biosciences's most recent funding round was Seed on October 28, 2024.

Who are the main investors in Paterna Biosciences?

Key investors in Paterna Biosciences include SpringTide Ventures.

Will Paterna Biosciences IPO soon?

No public IPO plans have been announced for Paterna Biosciences.

How can I track Paterna Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Paterna Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range15
Year Founded2020
Last FundingMay 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?